AT 1 receptors and L-type calcium channels: Functional coupling in supersensitivity to angiotensin II in diabetic rats

Cardiovascular Research

Volumn 65, Issue 2, 2005, Pages 374-386

  Arun, K H S ^a   Kaul, C L ^a   Ramarao, P ^a  

^a Department of Pharmaceutics   (India)

Author keywords

Angiotensin II; Diabetes; L type calcium channel; Streptozotocin; Thoracic aorta

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CALCIUM CHANNEL L TYPE; DILTIAZEM; NIMODIPINE; VERAPAMIL; ANGIOTENSIN II; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; ISRADIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; IC 50; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; THORACIC AORTA; VASCULAR RING; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL MEMBRANE; CHEMICAL PHENOMENA; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; IN VITRO STUDY; MALE; METABOLISM; MUSCLE CONTRACTION; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELL MEMBRANE; DEPRESSION, CHEMICAL; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ISRADIPINE; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NIMODIPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 11444264970     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.10.010     Document Type: Article

References (40)

1. M.E. Cooper, F. Bonnet, M. Oldfield, and K. Jandeleit-Dahm Mechanisms of diabetic vasculopathy: an overview Am. J. Hypertens. 14 2001 475 486
2. A.A. Taylor Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus Endocrinol. Metab. Clin. 30 4 2001 1 16
3. F. Cosentino, and T.F. Luscher Effects of blood pressure and glucose on endothelial function Curr. Hypertens. Rep. 3 2001 79 88
4. G.C. Schoonmaker, R.W. Fallet, and P.K. Carmines Superoxide anion curbs nitric oxide modulation of afferent arteriolar Ang II responsiveness in diabetes mellitus Am. J. Physiol. Renal. Physiol. 278 2000 F302 F309
5. S. Shastri, V. Gopalakrishnan, P. Ramarao, and H. Di Wang Tempol selectively attenuates angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats J. Hypertens. 20 2002 1381 1391
6. B.N. Srikumar, S. Shailesh, P. Ramarao, and C.L. Kaul Selective attenuation of enhanced angiotensin II mediated responses in the streptozotocin diabetic rat thoracic aorta by tempol G.N. Pierce P. Nagano N.S. Dhalla Atherosclerosis, hypertension and diabetes 2003 Kluwer Academic Publishers Boston 327 337
7. G. Jagadeesh Angiotensin II receptors-antagonists, molecular biology and signal transduction Indian J. Exp. Biol. 36 1998 1171 1194
8. P.B. Timmermans, P.C. Wong, A.T. Chiu, W.F. Herblin, P. Benfield, and D.J. Carini Angiotensin II receptor and angiotensin II receptor antagonists Pharmacol. Rev. 45 1993 205 251
9. 1 signalling in vascular smooth muscle J. Renin. Angiotensin Aldosterone Syst. 1 2000 125 130
10. i Am. J. Physiol. 271 1996 1340 1349
11. J.B. Smith, and T.A. Brock Analysis of angiotensin-stimulated sodium transport in cultured smooth muscle cells from rat aorta J. Cell. Physiol. 114 1983 284 290
12. c signals from calcium indicator dyes News Physiol. Sci. 15 2000 19 26
13. 2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260 1985 3440 3450
14. R. Waurick, J. Knapp, H. Vanaken, P. Boknik, J. Neumann, and W. Schmitz Effect of 2,3-butanedione monoxime on force of contraction and protein phosphorylation in bovine smooth muscle Naunyn-Schmiedebergs Arch. Pharmacol. 359 1999 484 492
15. M.P. Maillard, M. Lucia, D. Véronique, C. Catherine, N. Jürg, and R.B. Hans Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay Am. J. Hypertens. 12 1999 1201 1208
16. O.H. Lowry, N.F. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with folin phenol reagent J. Biol. Chem. 193 1951 265 275
17. R.D. Bunag, T. Tomita, and S. Sasaki Streptozotocin diabetic rats are hypertensive despite reduced hypothalamic responsiveness Hypertension 4 1982 556 565
18. Y.J. Liu, Y. Nakagawa, K. Toya, Y. Wang, H. Saegusa, and T. Nakanishi Effects of spironolactone on systolic blood pressure in experimental diabetic rats Kidney Int. 57 2000 2064 2071
19. L.E. Wold, D.P. Relling, P.B. Colligan, G.I. Scott, K.K. Hintz, and B.H. Ren Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes J. Mol. Cell. Cardiol. 33 2001 1719 1726
20. R. Nishigaki, F. Guo, M. Onda, N. Yamada, M. Yokoyama, and Z. Naito Ultrastructural changes and immunohistochemical localization of nitric oxide synthase, advanced glycation end products and NF-kappa B in aorta of streptozotocin treated mongolian gerbils Nippon Ika Daigaku Zasshi 66 1999 166 175
21. M. Zhou, H.J. Zhong, and X.Y. Wu Changes of ultrastructure and function of the aortic endothelium in streptozotocin-diabetic rats and effect of perindopril Hunan Yike Daxue Xuebao 26 2001 41 44
22. D. Vranes, M.E. Cooper, and R.J. Dilley Cellular mechanisms of diabetic vascular hypertrophy Microvasc. Res. 57 1999 8 18
23. R.M. Touyz, and E.L. Schiffrin Signal transduction mechanisms mediating the physiological and pathological actions of angiotensin II in vascular smooth muscle cells Pharmacol. Rev. 52 2000 639 672
24. G.M. Kravtsov, and C.Y. Kwan A revisitation on the mechanism of action of KCl-induced vascular smooth muscle contraction: a key role of cation binding to the plasma membrane Biol. Signals 4 1995 160 167
25. M.A. Noguera, S. Chulia, M. Elorriaga, M.D. Ivorra, and P. D'Ocon Effect of divalent cations on the contractile response of rat aorta to depolarization before and after nifedipine treatment Pharmacology 53 1996 98 108
26. 2+ channels via phosphoinositide 3-kinase FASEB J. 13 1999 685 694
27. 2+ channel, and it is functionally important in renal afferent arterioles Circ. Res. 87 2000 896 902
28. R. Candido, T.J. Allen, M. Lassila, Z. Cao, V. Thallas, and M.E. Cooper Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis Circulation 109 2004 1536 1542
29. K.C. Chang, S.Y. Chung, W.S. Chong, J.S. Suh, S.H. Kim, and H.K. Noh Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats J. Pharmacol. Exp. Ther. 266 1993 992 1000
30. M.G. Cinar, S. Ulker, G. Alper, and A. Evinc Effect of dietary vitamin E supplementation on vascular reactivity of thoracic aorta in streptozotocin- diabetic rats Pharmacology 62 2001 56 64
31. C.L. Kaul, and R.S. Grewal Vascular reactivity in streptozotocin-induced diabetic rat Pharmacol. Res. Commun. 12 1980 945 958
32. R.E. White, and G.O. Carrier Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes J. Pharmacol. Exp. Ther. 253 1990 1057 1062
33. C. Karasu, G. Ozansoy, O. Bozkurt, D. Erdogan, and S. Omeroglu Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-induced Complications (ADIC) study group Metabolism 46 1997 872 879
34. K.M. MacLeod, and J.H. McNeill The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels Can. J. Physiol. Pharmacol. 63 1985 52 57
35. N.N. Orie, and C.P. Aloamaka Duration-dependent variability in the responses of diabetic rat aorta to noradrenaline and 5-hydroxytryptamine Gen. Pharmacol. 24 1993 243 246
36. J.Y. Jeremy, A.P. Yim, S. Wan, and G.D. Angelini Oxidative stress, nitric oxide, and vascular disease J. Card. Surg. 17 2002 324 327
37. Y. Higashi, and M. Yoshizumi Endothelial function Nippon Rinsho 61 2003 1138 1144
38. 2 of nifedipine in the rat Acta Diabetol. 33 1996 114 117
39. 2+ influx is increased in 2-kidney, 1-clip hypertensive rat aorta Hypertension 38 2001 592 596
40. 2+ influx mediates enhanced alpha2-adrenergic contraction in aortas from rats treated with NOS inhibitor Am. J. Physiol. Heart Circ. Physiol. 281 2001 H2233 H2240